Conv. Plasma
Nigella Sativa
Nitric Oxide
Peg.. Lambda

Home   COVID-19 treatment studies for Vitamin A  COVID-19 treatment studies for Vitamin A  C19 studies: Vitamin A  Vitamin A   Select treatmentSelect treatmentTreatmentsTreatments
Alkalinization Meta Lactoferrin Meta
Melatonin Meta
Bromhexine Meta Metformin Meta
Budesonide Meta Molnupiravir Meta
Cannabidiol Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta Nitric Oxide Meta
Ensovibep Meta Paxlovid Meta
Famotidine Meta Peg.. Lambda Meta
Favipiravir Meta Povidone-Iod.. Meta
Fluvoxamine Meta Quercetin Meta
Hydroxychlor.. Meta Remdesivir Meta
Iota-carragee.. Meta
Ivermectin Meta Zinc Meta

Other Treatments Global Adoption
All Studies   Meta Analysis   Recent:  
0 0.5 1 1.5 2+ Mortality 86% Improvement Relative Risk Al-Sumiadai et al. Vitamin A for COVID-19 EARLY Is early treatment with vitamin A beneficial for COVID-19? Retrospective 140 patients in Iraq Lower mortality with vitamin A (p=0.0024) Al-Sumiadai et al., EurAsian J. Biosciences, 14:7347-7350 Favors vitamin A Favors control
Therapeutic effect of Vitamin A on severe COVID-19 patients
Al-Sumiadai et al., EurAsian Journal of Biosciences, 14:7347-7350
Al-Sumiadai et al., Therapeutic effect of Vitamin A on severe COVID-19 patients, EurAsian Journal of Biosciences, 14:7347-7350
Dec 2020   Source   PDF  
  All Studies   Meta
Retrospective 70 severe condition patients treated with vitamin A (200,000IU for two days), salbutamol, and budesonide, and 70 patients not treated with vitamin A, showing significantly lower mortality with the addition of vitamin A. This study is excluded in the after exclusion results of meta analysis: minimal details of groups provided.
risk of death, 85.7% lower, RR 0.14, p = 0.002, treatment 2 of 70 (2.9%), control 14 of 70 (20.0%), NNT 5.8.
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates
Al-Sumiadai et al., 31 Dec 2020, retrospective, Iraq, peer-reviewed, 3 authors.
All Studies   Meta Analysis   Submit Updates or Corrections
This PaperVitamin AAll
Abstract: See discussions, stats, and author profiles for this publication at: Therapeutic effect of Vitamin A on severe COVID-19 patients Article · December 2020 CITATION READS 1 50 3 authors, including: Hazim Ghazzay University of Anbar Wisam Zabin 4 PUBLICATIONS 1 CITATION 13 PUBLICATIONS 5 CITATIONS SEE PROFILE SEE PROFILE Some of the authors of this publication are also working on these related projects: Therapeutic effect of Vitamin A on severe COVID-19 patients View project Diarrhea is Atypical presentation of MI View project All content following this page was uploaded by Hazim Ghazzay on 31 May 2021. The user has requested enhancement of the EurAsian Journal of BioSciences Eurasia J Biosci 14, 7347-7350 (2020) Therapeutic effect of Vitamin A on severe COVID-19 patients Mahmood M. Al-Sumiadai 1*, Hazim Ghazzay 2, Wisam Zabin Saleh Al-Dulaimy 3 1 DCH, Ministry of Health, Anbar Health Directorate, Ramadi City, IRAQ F.I.C.M.S, Internal Medicine, Department of Medicine, College of Medicine, University of Anbar, IRAQ 3 CIB, Ministry of Health, Anbar Health Directorate, IRAQ *Corresponding author: 2 Abstract Objective: To find the effect of administration of vitamin A on patients with severe COVID-19. Material and Methods: A cross-sectional and retrospective study was done on two groups of patients with severe COVID-19 in isolation centers in Anbar governorate. The first group was patients with severe COVID-19 given two doses of vitamin A (200,000 I.U.) for two days from the first day of admission and three doses per day of salbutamol and budesonide nebulizers.. Data about the respiratory rate and SPO2 were collected after 48 and 96 hours from the administration in addition to the death rate among those patients. In a second group, the data was collected from files of patients with severe COVID-19 previously admitted to isolated centers and not receiving vitamin A. Results: A significant improvement in SPO2 and respiratory rate among severe COVID-19 patients given vitamin A as compared to those not given vitamin A. A lower death rate was recorded among severe COVID-19 patients who received vitamin A from those not received. Conclusions; A great benefit of the using of vitamin A in patients with severe COVID-19. Adding vitamin A to the regime COVID-19 therapy is recommended. Keywords: severe COVID-19, Vitamin A, therapeutic effect Al-Sumiadai MA, Ghazzay H, Al-Dulaimy WZH (2020) Article title Article title Article title Article title Article title Article title Article title Article title. Eurasia J Biosci 14: 7347-7350. © 2020 Al-Sumiadai et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License.
Please send us corrections, updates, or comments. Vaccines and treatments are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment, vaccine, or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop